@article{dahan:hal-01490466,
TITLE = {Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up},
AUTHOR = {Dahan, Karine and Debiec, Hanna and Plaisier, Emmanuelle and Cachanado, Marine and Rousseau, Alexandra and Wakselman, Laura and Michel, Pierre-antoine and Mihout, Fabrice and Dussol, Bertrand and Matignon, Marie and Mousson, Christiane and Simon, Tabassome and Ronco, Pierre and Vigneau, C{\'e}cile and Choukroun, Gabriel},
URL = {https://hal.sorbonne-universite.fr/hal-01490466},
NOTE = {on behalf of the GEMRITUX Study},
JOURNAL = {Journal of the American Society of Nephrology},
PUBLISHER = {American Society of Nephrology},
VOLUME = {28},
NUMBER = {1},
PAGES = {348-358},
YEAR = {2017},
MONTH = Jan, DOI = {10.1681/ASN.2016040449},
KEYWORDS = {severe adverse event ; anti-PLA2R antibody ; anti-THSD7A antibody ; idiopathic membranous nephropathy ; randomized controlled trial ; rituximab},
PDF = {https://hal.sorbonne-universite.fr/hal-01490466/file/Dahan_2017_Rituximab_for.pdf},
HAL_ID = {hal-01490466},
HAL_VERSION = {v1},
}